Jefferson Headache Center study shows novel, orally inhaled migraine therapy effective

Links shared publicly online about this topic.

1,831
total visits

Jefferson Headache Center study shows novel, orally inhaled migraine therapy effective

A new study conducted at the Jefferson Headache Center at Thomas Jefferson University Hospital in Philadelphia, Penn., shows an investigational, orally inhaled therapy is effective in treating migraines. The multicenter, phase three FREEDOM-301 trial for the orally inhaled migraine therapy, LEVADEX, shows study participants had significant relief from symptoms such as pain, nausea and light and sound sensitivity when compared to placebo treatment.

View full resource at eurekalert.org

Tags: Headache, Vascular Headache, Pain, Hospital, DHE 45, Migranal Nasal Spray, Hospitals, Jefferson University Hospitals

Most Recently Shared on August 11, 2009 at 6:29 pm By:

Stephen Roberts, MD

Study shows inhaled #migraine therapy effective http://ow.ly/jIRp LEVADEX: a novel formulation of dihydroergotamine (DHE)

3 years ago...

Retweet

Favorite

Study Shows Novel, Orally Inhaled Migraine Therapy Effective

newswise.com — “A new study conducted at the Jefferson Headache Center at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania shows an investigational, orally-inhaled therapy is effective in treating migraines. The multi-center, phase three FREEDOM-301 trial for the orally-inhaled migraine therapy, LEVADEX, shows study participants had significant relief from symptoms such as pain, nausea and light and sound sensitivity when compared to placebo treatment.” View full resource at newswise.com